RECRUITING

Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

62 patients who are one year post stroke and have Aphasia as a result of that stroke will be recruited. Participants will have 4 assessment sessions and 15 treatment sessions. The TDCS will be to right Inferior Frontal Gyrus (IFG) (25 active, 25 sham) for 15 days. A combined semantic feature analysis/phonological components analysis treatment will be paired with the stimulation. Two assessment sessions will be pretreatment, 1 session immediately post-treatment, and 1 session at 3 months follow-up.

Official Title

Targeted Transcranial Direct Current Stimulation to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia

Quick Facts

Study Start:2022-10-18
Study Completion:2026-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04432883

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. aged 25-85
  2. 2. must be greater than 1 year post-stroke
  3. 3. must have a diagnosis of aphasia based on impaired performance on the Western Aphasia Battery-Revised, Boston Naming Test, or during discourse production
  4. 4. must be left-hemisphere dominant as demonstrated by aphasia onset subsequent to left hemisphere damage
  5. 5. must be stimulable for naming
  1. 1. comorbid neurological disease.
  2. 2. damage to the anterior right hemisphere.
  3. 3. significant mood disorder.
  4. 4. substance/alcohol dependence or abuse within the past year
  5. 5. presence of any implanted electrical device or contraindications to tDCS or MRI
  6. 6. recent medical instability (within 4 weeks)
  7. 7. pregnancy

Contacts and Locations

Study Contact

Jessica Richardson, Ph.D.
CONTACT
505 277-1765
jdrichardson@unm.edu
Honey Hubbard
CONTACT
505-433-7766
hhubbard@unm.edu

Principal Investigator

Jessica Richardson, Ph.D.
PRINCIPAL_INVESTIGATOR
University of New Mexico

Study Locations (Sites)

University of New Mexico Center for Brain Recovery and Repair
Albuquerque, New Mexico, 87106
United States

Collaborators and Investigators

Sponsor: University of New Mexico

  • Jessica Richardson, Ph.D., PRINCIPAL_INVESTIGATOR, University of New Mexico

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-10-18
Study Completion Date2026-04-30

Study Record Updates

Study Start Date2022-10-18
Study Completion Date2026-04-30

Terms related to this study

Keywords Provided by Researchers

  • Stroke
  • Aphasia
  • brain stimulation
  • communication problems
  • speech and language therapy

Additional Relevant MeSH Terms

  • Stroke
  • Aphasia